These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11596484)

  • 1. [Neuropathology of longstanding subacute myelo-optico-neuropathy (SMON): an autopsy case of SMON with duration of 28 years].
    Konno H; Takase S; Fukui T
    No To Shinkei; 2001 Sep; 53(9):875-80. PubMed ID: 11596484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropathology of subacute myelo-optico-neuropathy, "SMON", in the humans: --with special reference to the quinoform intoxication.
    Shiraki H
    Jpn J Med Sci Biol; 1975; 28 Suppl():101-64. PubMed ID: 136535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.
    Egashira Y; Matsuyama H
    Acta Pathol Jpn; 1982; 32 Suppl 1():101-16. PubMed ID: 6316716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spinal anesthesia for a patient with long-term SMON].
    Yuasa H; Higashizawa T; Shiokawa Y; Tanaka T; Koga Y
    Masui; 1999 Jan; 48(1):79-80. PubMed ID: 10036897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropathology of subacute myelo-optico-neuropathy, (SMON)].
    Shiraki H; Oda M
    Saishin Igaku; 1969 Dec; 24(12):2479-509. PubMed ID: 5363408
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropathology of subacute myelo-optico-neuropathy, "SMON".
    Shiraki H
    Jpn J Med Sci Biol; 1971 Aug; 24(4):217-43. PubMed ID: 5316312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Abnormalities in the pyramidal tract in subacute myelo-optico-neuropathy (SMON)--study using percutaneous cortical and spinal stimulation].
    Kachi T; Yamada T; Sobue G; Hayashi F; Sobue I
    Rinsho Shinkeigaku; 1987 Mar; 27(3):360-5. PubMed ID: 3608328
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative histological change of myelinated nerve fibers and its significance. (II) In SMON(subacute-myelo-optico-neuropathy)].
    Matsuoka Y; Mukoyama M; Takayanagi T; Sobue I
    Rinsho Shinkeigaku; 1977 May; 17(5):310-5. PubMed ID: 560277
    [No Abstract]   [Full Text] [Related]  

  • 9. [SMON--a model of the iatrogenic disease].
    Takasu T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinesiometric analysis of motor dysfunction in patients with subacute myelo-optico neuropathy (SMON).
    Toyoshima E; Tomi H; Mano Y; Ando K; Mayer RF
    Electromyogr Clin Neurophysiol; 1987; 27(6-7):363-9. PubMed ID: 3428215
    [No Abstract]   [Full Text] [Related]  

  • 11. Micturitional disturbance in subacute myelo-optico-neuropathy (SMON).
    Sakakibara R; Hattori T; Uchiyama T; Yamanishi T
    Auton Neurosci; 2001 Mar; 87(2-3):282-5. PubMed ID: 11476290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short history of autopsy study of SMON in Japan and principal lesions of the spinal cord in 113 autopsy cases: Section of Pathology, SMON Research Commission.
    Egashira Y
    Jpn J Med Sci Biol; 1975; 28 Suppl():63-7. PubMed ID: 1234603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histo-pathology of the optic nerve and eyeball in SMON (subacute myelo-optico neuropathy)].
    Okuda K; Ueno H
    Nippon Ganka Gakkai Zasshi; 1970 Sep; 74(9):1145-51. PubMed ID: 5528718
    [No Abstract]   [Full Text] [Related]  

  • 14. Introductory review of subacute myeolo-optico-neuropathy (SMON) and its studies done by the SMON Research Commission.
    Kono R
    Jpn J Med Sci Biol; 1975; 28 Suppl():1-21. PubMed ID: 136534
    [No Abstract]   [Full Text] [Related]  

  • 15. Diminished skin vasodilator response to local heating in patients with long-standingsubacute myelo-optico-neuropathy.
    Yamanaka Y; Asahina M; Akaogi Y; Koyama Y; Hattori T
    J Neurol Sci; 2007 Sep; 260(1-2):214-8. PubMed ID: 17572442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated T cells in the peripheral blood of patients with subacute myelo-optico-neuropathy (SMON)].
    Matsuda M; Miyagi K; Yanagisawa N; Tsukada N
    Arerugi; 1994 Mar; 43(3):515-20. PubMed ID: 8198461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perception threshold in subacute myelo-optico-neuropathy.
    Suzuki Y; Ogawa K; Shiota H; Kamei S; Oishi M; Mizutani T
    Int J Neurosci; 2010 May; 120(5):368-71. PubMed ID: 20402576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-related changes of B-cell immune function in patients with subacute myelo-optico-neuropathy (SMON)].
    Matsuda M; Miyagi K; Yanagisawa N; Tsukada N
    Arerugi; 1994 Sep; 43(9):1215-9. PubMed ID: 7802607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experiences of PISCES (percutaneously inserted spinal cord electrical stimulation) in SMON and other neurologic disorders].
    Tani S; Shimizu H; Ishijima B; Hanakago R
    No To Shinkei; 1984 Apr; 36(4):383-8. PubMed ID: 6611163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SMON, subacute-myelo-optico-neuropathy].
    Shimada N
    Nihon Ishikai Zasshi; 1969 Oct; 62(8):788-92. PubMed ID: 5389302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.